Lista de obras -

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?

artículo científico publicado en 2017

An early improvement threshold to predict response and remission in first-episode schizophrenia

artículo científico publicado en 2010

Attitude towards adherence in patients with schizophrenia at discharge

artículo científico publicado en 2009

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol

artículo científico publicado en 2011

Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients

artículo científico publicado en 2010

Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

artículo científico publicado en 2012

Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnesses

artículo científico publicado en 2008

Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses

artículo científico publicado en 2009

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder

artículo científico publicado en 2011

Low performance in attention testing is associated with reduced grey matter density of the left inferior frontal gyrus in euthyroid patients with Hashimoto’s thyroiditis ⬇️

artículo científico publicado el 23 de septiembre de 2012

One-year functional outcomes of naturalistically treated patients with schizophrenia

artículo científico publicado en 2012

Predictors of relapse in the year after hospital discharge among patients with schizophrenia

artículo científico publicado en 2012

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

article by Rebecca Schennach-Wolff et al published May 2011 in European Neuropsychopharmacology

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?

artículo científico publicado en 2010

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial

artículo científico publicado en 2012

Response trajectories in "real-world" naturalistically treated schizophrenia patients

artículo científico publicado en 2012

Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto's thyroiditis

artículo científico publicado en 2012

Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adults

artículo científico publicado en 2009

Lista de obras de

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?

An early improvement threshold to predict response and remission in first-episode schizophrenia

Attitude towards adherence in patients with schizophrenia at discharge

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol

Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients

Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnesses

Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder

Low performance in attention testing is associated with reduced grey matter density of the left inferior frontal gyrus in euthyroid patients with Hashimoto’s thyroiditis ⬇️

One-year functional outcomes of naturalistically treated patients with schizophrenia

Predictors of relapse in the year after hospital discharge among patients with schizophrenia

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial

Response trajectories in "real-world" naturalistically treated schizophrenia patients

Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto's thyroiditis

Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adults